• Immunofluorescence analysis of HepG2 cells, using MTR1A Antibody. The picture on the right is blocked with the synthesized peptide.

Anti-MTNR1A antibody (191-240 aa) (STJ94091)

SKU:
STJ94091

Current Stock:
Host: Rabbit
Applications: WB/ELISA/IHC
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Melatonin receptor type 1A (191-240 aa) is suitable for use in Western Blot, ELISA and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
IHC-P 1:50-300
ELISA 2000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MTNR1A
Gene ID: 4543
Uniprot ID: MTR1A_HUMAN
Immunogen Region: 191-240 aa
Specificity: MEL-1A-R Polyclonal Antibody detects endogenous levels of MEL-1A-R protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human MTR1A at the amino acid range 191-240
Function High affinity receptor for melatonin. Likely to mediate the reproductive and circadian actions of melatonin. The activity of this receptor is mediated by pertussis toxin sensitive G proteins that inhibit adenylate cyclase activity.
Protein Name Melatonin Receptor Type 1a
Mel-1a-R
Mel1a Receptor
Database Links Reactome: R-HSA-373076
Reactome: R-HSA-418594
Cellular Localisation Cell Membrane
Multi-Pass Membrane Protein
Alternative Antibody Names Anti-Melatonin Receptor Type 1a antibody
Anti-Mel-1a-R antibody
Anti-Mel1a Receptor antibody
Anti-MTNR1A antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance